Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Hakan Kardes Sells 20,500 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 20,500 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $13.06, for a total transaction of $267,730.00. Following the completion of the sale, the insider now owns 355,444 shares in the company, valued at approximately $4,642,098.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Hakan Kardes also recently made the following trade(s):

• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.98, for a total value of $58,410.00.
• On Thursday, September 12th, Hakan Kardes sold 25,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.48, for a total value of $287,000.00.

Alignment Healthcare Price Performance

Shares of ALHC stock opened at $13.78 on Friday. The company’s 50-day simple moving average is $11.08 and its two-hundred day simple moving average is $9.00. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. During the same period last year, the business posted ($0.19) EPS. Alignment Healthcare’s quarterly revenue was up 51.6% on a year-over-year basis. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.68 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on ALHC. Piper Sandler reissued an “overweight” rating and set a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. Barclays boosted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Robert W. Baird raised their target price on shares of Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a report on Wednesday, August 14th. TD Cowen upped their price target on shares of Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a report on Tuesday, August 6th. Finally, KeyCorp assumed coverage on shares of Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $10.33.

Institutional Trading of Alignment Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. Royce & Associates LP purchased a new position in Alignment Healthcare during the 3rd quarter valued at about $3,782,000. Principal Financial Group Inc. boosted its stake in shares of Alignment Healthcare by 1,335.1% during the third quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after purchasing an additional 180,522 shares in the last quarter. nVerses Capital LLC purchased a new position in Alignment Healthcare during the third quarter valued at approximately $95,000. Creative Planning increased its holdings in Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after buying an additional 2,072 shares during the period. Finally, SG Americas Securities LLC bought a new position in Alignment Healthcare in the third quarter worth approximately $521,000. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.